Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001387131-13-001537
Filing Date
2013-05-03
Accepted
2013-05-03 17:06:05
Documents
1

Document Format Files

Seq Description Document Type Size
1 INFORMATION STATEMENT milligan-sc13d_050113.htm SC 13D 76907
  Complete submission text file 0001387131-13-001537.txt   78477
Mailing Address 951 BROKEN SOUND PARKWAY NW SUITE 320 BOCA RATON FL 33487
Business Address 951 BROKEN SOUND PARKWAY NW SUITE 320 BOCA RATON FL 33487 561-961-1911
TherapeuticsMD, Inc. (Subject) CIK: 0000025743 (see all company filings)

EIN.: 870233535 | State of Incorp.: NV | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-32384 | Film No.: 13813565
SIC: 2834 Pharmaceutical Preparations

Mailing Address 951 BROKEN SOUND PARKWAY NW SUITE 320 BOCA RATON FL 33487
Business Address
Milligan John C.K. IV (Filed by) CIK: 0001532230 (see all company filings)

Type: SC 13D